Rachel J. Gorwitz

TL;DR: These guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system infections.

TL;DR: Although universal screening for GBS colonization is anticipated to result in further reductions in the burden of GBS disease, the need to monitor for potential adverse consequences of intrapartum antibiotic use, such as emergence of bacterial antimicrobial resistance or increased incidence or severity of non-GBS neonatal pathogens, continues.

TL;DR: MRSA is the most common identifiable cause of skin and soft-tissue infections among patients presenting to emergency departments in 11 U.S. cities and clinicians should consider obtaining cultures and modifying empirical therapy to provide MRSA coverage.

TL;DR: Nal colonization with MRSA has increased in the United States, despite an overall decrease in nasal colonization with S. aureus, and PFGE types associated with community transmission only partially account for the increase.

TL;DR: This report replaces CDC's 1996 guidelines with recommendations based on available evidence and expert opinion where sufficient evidence was lacking, and includes some key changes.